Cogent Biosciences
COGT
COGT
27 hedge funds and large institutions have $6.99M invested in Cogent Biosciences in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
61% less capital invested
Capital invested by funds: $17.8M → $6.99M (-$10.8M)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
27
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$246K | |
| 2 | +$108K | |
| 3 | +$97K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$54.3K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.5K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$991K | |
| 3 | -$682K | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$366K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$144K |